Pharma Polymer Manufacturers in India
Speciality Polymers Manufacturers in India
Shilpa Pharma is a leading polymer manufacturer in India, specializing in the development and supply of high-quality pharmaceutical polymers such as PBD-B-PEO (Polybutadiene-block-Polyethylene oxide) and other custom polymers. With state-of-the-art R&D capabilities and GMP-compliant facilities, we provide innovative polymer solutions that support both oncology and non-oncology formulations.
Our polymers play a vital role in enhancing drug solubility, stability, and delivery efficiency across a wide range of therapeutic areas. Backed by strong expertise in polymer synthesis, characterization, and scale-up, we cater to global pharmaceutical companies with reliable and tailor-made solutions.
At Shilpa Pharma, we ensure strict adherence to international regulatory standards, providing comprehensive documentation and IPR support for global submissions. With a commitment to innovation, quality, and sustainability, we continue to advance as one of the most trusted names among polymer suppliers in the pharmaceutical industry.
For Polymer Enquiries mail us on:
info@shilpapharma.com
Complete Range of Polymer Pharmaceuticals
| Polymers for Pharma & Biomedical Applications | ||||
|---|---|---|---|---|
| S. NO. | PRODUCT NAME | M.Wt kDa | Application | CAS No |
| 1 | Methoxy polyethylene glycol (mPEG) |
5, 10 & 20 | FOR DRUG DELIVERY, Peptide & Protein APPLICATIONS | 9004-74-4 |
| 2 | MONODISPERSE POLYETHYLENE GLYCOL |
PEG-9, PEG-8 | ADC Applications | 25322-68-3 |
| 3 | POLYLACTIDES |
5, 10, 20 | For Long acting Deliverable applications | 26100-51-6 |
| 4 | Poly(lactide-co-glycolide) (PLGA) |
10, 20, 40 & 50 | For Long acting Deliverable applications | 26780-50-7 |
| 5 | SILICON BASED COPOLYMERS |
5, 10, 30 kDa | Pressure sensitive Adhesive | - |
| 6 | POLYOXAZOLINE |
5, 10, 20 kDa | For Drug DELIVERY | 25805-17-8 |
| 7 | POLYETHYLENIMINE HYDROCHLORIDE |
5, 10, 20 | For gene delivery applications | 25987-06-8 |
| 8 | POLYETHYLENIMINE |
5, 10 kDa | For gene delivery applications | 9002-98-6 |
| 9 | poly(N-isopropylacrylamide) |
10, 20, 40 & 80 | For Drug Deliver Applications | 25189-55-3 |
| 10 | Polyacrylic acid/ Sodium Polyacrylate |
100 | Superabsorbants | 9003-01-4 |
| 11 | Polyvinyl alcohol |
50 | Biomedical Applications | 9002-89-5 |
| 12 | Poly(N,N-dimethylacrylamide) |
10, 20 & 100 | Drug delivery & Biomedical applications | 26793-34-0 |
| 13 | Polyacrylate copolymers |
upto 100 | Biomedical Applications | 25133-97-5 |
| 14 | Polylutamic Acid |
5, 10 | Drug delivery | 25513-46-6 |
Request a Quote for Pharma Polymers Today
Tailored Polymer Solutions
From synthesis to functionalization, we deliver polymers for advanced drug delivery and medical devices.
Advanced Drug Delivery Applications
Specialized PBD-b-PEO polymers for controlled release and targeted therapies.
Integrated R&D & GMP Manufacturing
State-of-the-art facilities ensure scalable, compliant, and high-quality polymer production.
Our Expertise at a Glance
Leading the Way in Pharma Innovation
1987
Established
100+
R&D workforce
1500+
Team size
3
Manufacturing site
100+
Audits
500+
Customers
100+
Projects
Shilpa Pharma’s Portfolio of Pharmaceutical Polymers
Shilpa Pharma develops and manufactures specialized pharmaceutical polymers such as Polybutadiene-block-Polyethylene Oxide (PBD-b-PEO) at advanced cGMP-compliant facilities in India. As a trusted partner offering CDMO services in India, our manufacturing blocks are equipped to deliver high-quality polymers that meet the stringent requirements of international regulatory authorities including USFDA, EU GMP, ANVISA, COFEPRIS, TGA, PMDA, and KFDA, making them suitable for use in global markets.
Our dedicated R&D team applies expertise in polymer synthesis, process development, and formulation sciences to create innovative polymer solutions that support a wide range of therapeutic applications, from oncology to advanced drug delivery systems. Each polymer undergoes rigorous characterization and analytical testing to ensure optimal purity, stability, and performance.
By integrating cutting-edge polymer science with scalable manufacturing, Shilpa Pharma empowers pharmaceutical companies worldwide to develop safe, effective, and reliable therapies. With a strong focus on quality, regulatory compliance, and innovation, and by providing end-to-end CDMO services in India, we continue to expand our polymer portfolio to meet the evolving needs of the global healthcare industry.